Literature DB >> 1955442

Sickle cell disease and silent avascular necrosis of the hip.

H E Ware1, A P Brooks, R Toye, S I Berney.   

Abstract

We reviewed the prevalence of avascular necrosis (AVN) in a series of patients with sickle cell disease, using radiography and magnetic resonance imaging. We found AVN of at least one hip in 11 of 27 patients (41%). This is a significantly greater prevalence than reported. MRI was not as helpful in patients with sickle cell disease as it is in patients with AVN from other causes; it detected no more cases than radiography.

Entities:  

Mesh:

Year:  1991        PMID: 1955442

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  17 in total

1.  Type I collagen as a marker of bone metabolism in sickle cell hemoglobinopathies.

Authors:  D M Bolarin; P Swerdlow; A M Wallace; L Littsey
Journal:  J Natl Med Assoc       Date:  1998-01       Impact factor: 1.798

2.  Avascular Necrosis of Femoral Head in a Child with Beta Thalassaemia Major.

Authors:  Adharsh Narain Thulasidhar; Sandeep Kumar; Shrikiran Aroor; Suneel Mundkur
Journal:  J Clin Diagn Res       Date:  2016-09-01

3.  The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations.

Authors:  Amanda M Brandow; Steven J Weisman; Julie A Panepinto
Journal:  Pediatr Blood Cancer       Date:  2010-12-15       Impact factor: 3.167

4.  Symptomatic Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization by Patients with SCD.

Authors:  Tiffany Yu; Timothy Campbell; Isabella Ciuffetelli; Carlton Haywood; Christopher Patrick Carroll; Linda Resar; John J Strouse; Sophie Lanzkron
Journal:  South Med J       Date:  2016-09       Impact factor: 0.954

5.  Hemoglobin to Hematocrit Ratio: The Strongest Predictor of Femoral Head Osteonecrosis in Children With Sickle Cell Disease.

Authors:  Douglas Worrall; Kim Smith-Whitley; Lawrence Wells
Journal:  J Pediatr Orthop       Date:  2016-03       Impact factor: 2.324

6.  Spectrum of musculo-skeletal disorders in sickle cell disease in Lagos, Nigeria.

Authors:  Rufai A Balogun; Dike C Obalum; Suleiman O Giwa; Thomas O Adekoya-Cole; Chidiebere N Ogo; George O Enweluzo
Journal:  J Orthop Surg Res       Date:  2010-01-18       Impact factor: 2.359

7.  Microarchitectural and mechanical characterization of the sickle bone.

Authors:  Mykel Green; Idowu Akinsami; Angela Lin; Shereka Banton; Samit Ghosh; Binbin Chen; Manu Platt; Ifeyinwa Osunkwo; Solomon Ofori-Acquah; Robert Guldberg; Gilda Barabino
Journal:  J Mech Behav Biomed Mater       Date:  2015-04-24

Review 8.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

9.  Microparticles as biomarkers of osteonecrosis of the hip in sickle cell disease.

Authors:  Anne Marsh; Raymond Schiffelers; Frans Kuypers; Sandra Larkin; Ginny Gildengorin; Wouter van Solinge; Carolyn Hoppe
Journal:  Br J Haematol       Date:  2014-09-06       Impact factor: 6.998

10.  Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging.

Authors:  S Sharma; W-H Leung; P Deqing; J Yang; R Rochester; L Britton; M D Neel; K K Ness; S C Kaste
Journal:  Bone Marrow Transplant       Date:  2011-12-12       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.